Panel Discussion: Spearheading the New Wave of Therapies & Approaches to Treating HFpEF

Time: 2:30 pm
day: Day Two


  • Sharing latest data on the categories of medications that are on the threshold of being in the next phase-II and phase-III clinical trials
  • Understanding the landscape of CCB, Baroreflex and other therapies in the production pipeline and the impacts these could have on HFpEF patients